Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.2K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Target Perturbation of Genetically Proxied Antidiabetic Drug Targets and Pneumonia Risk: A Mendelian Randomization Analysis.

Current topics in medicinal chemistry·2026
Same author

Preoperative prehabilitation in adults: A concept analysis.

International journal of nursing studies advances·2026
Same author

Self-supporting BiVO<sub>4</sub>@UiO-66-CdS QD hierarchical scaffold-based heterojunction band alignment for synergistic gain optoelectronic organic transistor sensing.

Biosensors & bioelectronics·2026
Same author

Revisiting ADMET prediction reliability under real-world challenges in the foundation model era.

Journal of cheminformatics·2026
Same author

Embedded timing and alert device triggered by total dissolved solids (TDS) for monitoring disinfection duration in acidic electrolyzed oxidizing water.

PloS one·2026
Same author

CtBP promoted P4HB mediates SLC7A11 maturation to confer ferroptosis resistance in triple-negative breast cancer.

Journal of experimental & clinical cancer research : CR·2026
Same journal

A Dataset with Bilingual TV Commands for Silent Speech Interfaces Using Electroencephalographic Signals.

Scientific data·2026
Same journal

BEAMSTER: Brain mEtAstases segMentation for STEreotactic Radiotherapy, A Retrospective MRI Dataset with Expert Segmentations.

Scientific data·2026
Same journal

Chromosomal-level genome assembly of Tetraponera attenuata (Hymenoptera: Formicidae).

Scientific data·2026
Same journal

High quality Chromosome-scale Genome Assembly of Phlebotomus perniciosus, a Vector of Zoonotic Leishmaniasis.

Scientific data·2026
Same journal

Characterisation Data of common pharmaceutical excipient Powders and Tablets for Formulation Development.

Scientific data·2026
Same journal

Chinese Electric Vehicle Policy Database: A Dataset of Policy Goals, Instruments, and Supply Chain Stages.

Scientific data·2026
See all related articles

Related Experiment Video

Updated: Jan 16, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.2K

TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction.

Jintai Chen1, Yaojun Hu2, Mingchen Cai3,4

  • 1AI Thrust, Information Hub, HKUST(GZ), Guangzhou, Guangdong, China. jintaiCHEN@hkust-gz.edu.cn.

Scientific Data
|September 26, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces 23 AI-ready datasets for clinical trial design, enabling predictions for trial duration, patient dropout, and adverse events. These resources aim to improve clinical trial efficiency and accelerate medical treatment development.

More Related Videos

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K

Related Experiment Videos

Last Updated: Jan 16, 2026

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.2K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.0K

Area of Science:

  • Biomedical Informatics
  • Clinical Trial Management
  • Artificial Intelligence in Medicine

Background:

  • Clinical trials are essential for medical advancements but face significant risks like patient mortality and enrollment failure, leading to wasted resources.
  • The integration of artificial intelligence (AI) in clinical trials can offer predictive insights for design optimization, but has been limited by data complexity and the need for medical expertise.
  • Existing challenges in clinical trial design necessitate novel approaches to mitigate risks and improve efficiency.

Purpose of the Study:

  • To address the limitations in applying AI to clinical trial design by creating accessible, AI-ready datasets.
  • To facilitate the prediction of key clinical trial outcomes and design parameters using AI.
  • To accelerate the development of AI-driven tools for optimizing clinical trial design and execution.

Main Methods:

  • Curated a comprehensive suite of 23 multi-modal, AI-ready datasets.
  • Covered 8 critical prediction challenges in clinical trial design, including duration, dropout rates, adverse events, and approval outcomes.
  • Included basic validation methods for each dataset to ensure usability and reliability.

Main Results:

  • Developed 23 meticulously curated datasets suitable for AI model training.
  • Enabled prediction for crucial aspects of clinical trials such as duration, patient dropout, serious adverse events, mortality, approval outcomes, failure reasons, drug dosage, and eligibility criteria.
  • Provided validated datasets to support AI-driven clinical trial design.

Conclusions:

  • The release of these open-access datasets is expected to stimulate the development of advanced AI methodologies for clinical trial design.
  • This initiative aims to enhance the efficiency and success rates of clinical trials.
  • The availability of these resources will contribute to accelerating the development and delivery of medical solutions.